Quadrapax

Quadrapax

Quadrapax Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Heat prostration can occur with belladonna alkaloids in high temperatures.

Diarrhea may be an early symptom of incomplete intestinal obstruction, especially in patients with ileostomy or colostomy.  In this instance, treatment with this drug could be harmful.

Quadrapax Elixir may produce drowsiness and blurred vision.  The patient should be warned about engaging in hazardous work or activities requiring mental alertness, such as operating a motor vehicle or other machinery.  Phenobarbital may decrease the effect of anticoagulants, and larger doses of the anticoagulant may be needed for optimal effect.  When phenobarbital is discontinued, the dose of the anticoagulant may have to be decreased.  Phenobarbital may be habit forming and should not be administered to patients who are susceptible to addiction or to those with a history of physical and/or psychological drug dependence.

Barbiturates should be used with caution in patients with hepatic dysfunction.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

FDA has classified the following indications as "possibly" effective:  For use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis.  May also be useful as adjunctive therapy in the treatment of duodenal ulcer. 
IT HAS NOT BEEN SHOWN CONCLUSIVELY WHETHER ANTICHOLINERGIC/ANTISPASMODIC DRUGS AID IN THE HEALING OF A DUODENAL ULCER, DECREASE THE RATE OF RECURRENCES OR PREVENT COMPLICATIONS.

History

There is currently no drug history available for this drug.

Other Information

Each 5 mL (one teaspoonful) for oral administration contains:
Phenobarbital, USP.......................................................16.2 mg
  ( WARNING:  May be habit forming)
Hyoscyamine sulfate, USP.........................................0.1037 mg
Atropine sulfate, USP.................................................0.0194 mg
Scopolamine hydrobromide, USP................................0.0065  mg
Alcohol...............................................................................23%

Quadrapax Manufacturers


  • Acella Pharmaceuticals, Llc
    Quadrapax (Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide) Elixir [Acella Pharmaceuticals, Llc]
  • Rebel Distributors Corp
    Quadrapax (Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide) Elixir [Rebel Distributors Corp]

Login To Your Free Account